GGrantIndex
Sort

141,003 grants matching cytokine

Blocking Arsenicals-induced Cutaneous Injury

$733,530
Mohammad Athar · University Of Alabama At Birmingham · U01 · FY2016 · NS

Blocking Arsenicals-induced Cutaneous Injury

$733,530
Mohammad Athar · University Of Alabama At Birmingham · U01 · FY2017 · NS

Blocking Arsenicals-induced Cutaneous Injury

$733,530
Mohammad Athar · University Of Alabama At Birmingham · U01 · FY2019 · NS

Blocking Arsenicals-induced Cutaneous Injury

$733,530
Mohammad Athar · University Of Alabama At Birmingham · U01 · FY2015 · NS

Targeting the Cholinergic Pathway in HIV-associated Inflammation and Cognitive Dysfunction

$733,510
Rebecca Ashare · University Of Pennsylvania · R01 · FY2021 · DA

HIV-induced neuroinflammation associated with opiod abuse and tobacco smoke

$733,470
Thomas J Rogers · Temple Univ Of The Commonwealth · R01 · FY2016 · DA

Host Genetics of HIV-1 Subtype C Infection, Progression, and Treatment in Africa

$733,469
Myron E Essex · Harvard School Of Public Health · R01 · FY2008 · AI

Designer Probiotics for the treatment of intestinal infection and inflammation

$733,448
Cammie Lesser · Massachusetts General Hospital · R01 · FY2020 · DK

Molecular Regulation of B-Cell Differentiation and Function

$733,388
Herbert Morse · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Epigenetics of the autoantibody response in systemic lupus

$733,336
Paolo Casali · University Of Texas Hlth Science Center · R01 · FY2021 · AI

Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa

$733,316
Craig R Cohen · University Of California, San Francisco · R01 · FY2021 · HD

Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma

$733,308
Mark Yarchoan · Johns Hopkins University · R01 · FY2022 · CA

Mechanisms of SIV suppression by CD8+ lymphocytes

$733,243
Guido Silvestri · Emory University · R01 · FY2013 · AI

Preclinical development of a synthetic lung surfactant dry powder aerosol for hypoxemia or acute respiratory distress syndrome patients receiving different modes of ventilation support

$733,241
P. Worth Longest · Virginia Commonwealth University · R01 · FY2024 · HL

Clarifying the overlapping pathology of delirium and dementia

$733,240
Robert A Pearce · University Of Wisconsin-Madison · R01 · FY2020 · AG

Molecular Pathways of Innate Immunity and Substance Abuse in NeuroHIV

$733,223
Joao Filipe Inacio Mamede · Rush University Medical Center · R33 · FY2025 · DA

IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS

$733,183
David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

HIV-1 Infection In Fetal Brain Cell Cultures And Pediatric Aids Brain Tissue

$733,169
Eugene O. Major · Neurological Disorders And Stroke · Z01 · FY2007 · NS

Probenecid for Alcohol Use Disorder

$733,137
Carolina Luisa Haass-Koffler · Brown University · R01 · FY2025 · AA

Acute HCV Infection in Injection Drug Users

$733,105
Brian R. Edlin · Weill Medical Coll Of Cornell Univ · R01 · FY2006 · DA

Intermittent Hypoxia and Caffeine in Infants Born Preterm

$733,084
Carl E. Hunt · Children'S Research Institute · R01 · FY2018 · HD

Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity

$733,069
Hao Wu · Boston Children'S Hospital · R01 · FY2025 · CA

Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity

$733,069
Hao Wu · Boston Children'S Hospital · R01 · FY2024 · CA

Project 3: Neurodevelopment in an NHP MIA model

$733,034
Melissa Dawn Bauman · University Of California At Davis · P50 · FY2025 · MH

Antibody Responses in Aging SIV Infected Monkeys

$733,027
Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2019 · AI